News for Medtronic plc (MDTN.MX)

We came across a bullish thesis on Abbott Laboratories on r/ValueInvesting subreddit by anonymous_sheep1. In this article, we will summarize the bulls’ thesis on ABT. Abbott Laboratories’ share was trading at $120.51 as of July 17th. ABT’s trailing and forward P/E were 15.12 and 23.42, respectively, according to Yahoo Finance. Abbott Laboratories (ABT) delivered quarterly results that […]

We came across a bullish thesis on Medtronic plc on Max Dividends’s Substack. In this article, we will summarize the bulls’ thesis on MDT. Medtronic plc’s share was trading at $89.22 as of July 15th. MDT’s trailing and forward P/E were 24.71 and 16.03, respectively according to Yahoo Finance. Medtronic (NYSE: MDT) stands out as a dependable […]

Medtronic's MiniMed 780G system now has CE mark approval in Europe for an expanded age group. Wall Street analysts forecast a potential upside of 7.09%

Summary Medtronic PLC (MDT) has been collaborating with the nonprofit organization SpineHope since 2008 to provide essential medical treatment to children suffe

Mizuho analyst Anthony Petrone has raised the price target for Medtronic (MDT) from $98.00 to $100.00, marking a 2.04% increase. This adjustment reflects an opt

On July 15, 2025, Medtronic (MDT) received a revised price target from Morgan Stanley. The financial services company adjusted the price target for MDT, raising

Morgan Stanley has increased its price target for Medtronic (MDT) from $98 to $107, maintaining an Overweight rating for the company's shares. The firm expresse

Medtronic (MDT) has attracted attention in the options market with notable bearish activity. A total of 5,070 put options were traded, tripling the usual volume

Medtronic (MDT) investors have an opportunity to enhance their investment strategies with advanced tools and expert analysis. The Fly now offers its timely stoc

BTIG analyst Ryan Zimmerman maintains a Neutral stance on Medtronic (MDT) following the Centers for Medicare and Medicaid Services (CMS) proposal for national c

Medtronic (MDT) has recently seen unusual activity in its options trading. This surge in interest highlights a significant change in the investment patterns for

Stifel has reiterated its Hold rating on Medtronic (MDT), setting a price target of $87 for the medical technology company. A proposal from the Centers for Medi

JPMorgan maintains a Neutral stance on Medtronic (MDT) following a proposal from the Centers for Medicare and Medicaid Services regarding national coverage for

The Centers for Medicare and Medicaid Services (CMS) announced that it has received a comprehensive, formal application to cover renal denervation. This innovat

Hewlett Packard Enterprise is training finance professionals to work with AI agents.

On July 9, 2025, Citigroup maintained its "Buy" rating on Medtronic (MDT) while adjusting its price target for the stock. The updated price target has been rais

Summary Medtronic PLC (MDT) recently announced a unique collaboration with the Wildlife Science Center and the Smithsonian's National Zoo and Conservation Biolo

Citi analyst Joanne Wuensch has increased the price target for Medtronic (MDT) to $99, slightly up from the previous $98, while maintaining a Buy rating on the

The company counts NATO and OpenAI among its prominent and wide-ranging client pool.